Cargando…

Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine

Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Tzu-Chieh, Lee, Wen-Yuan, Chen, Kuen-Bao, Chan, Yueh-Chiu, Chen, Calvin Yu-Chian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098895/
https://www.ncbi.nlm.nih.gov/pubmed/25054138
http://dx.doi.org/10.1155/2014/321486
_version_ 1782326400719519744
author Hung, Tzu-Chieh
Lee, Wen-Yuan
Chen, Kuen-Bao
Chan, Yueh-Chiu
Chen, Calvin Yu-Chian
author_facet Hung, Tzu-Chieh
Lee, Wen-Yuan
Chen, Kuen-Bao
Chan, Yueh-Chiu
Chen, Calvin Yu-Chian
author_sort Hung, Tzu-Chieh
collection PubMed
description Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking and molecular dynamics to regulate ESR1. S-Allylmercaptocysteine and 5-hydroxy-L-tryptophan are selected according to the highest docking score than that of other TCM compounds and Raloxifene (control). The simulation from molecular dynamics is helpful in analyzing and detecting the protein-ligand interactions. After a comparing the control and the Apo form, then based on the docking poses, hydrophobic interactions, hydrogen bond and structure variations, this research postulates that S-allylmercaptocysteine may be more appropriate than other compounds for protein-ligand interaction.
format Online
Article
Text
id pubmed-4098895
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40988952014-07-22 Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine Hung, Tzu-Chieh Lee, Wen-Yuan Chen, Kuen-Bao Chan, Yueh-Chiu Chen, Calvin Yu-Chian Biomed Res Int Research Article Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking and molecular dynamics to regulate ESR1. S-Allylmercaptocysteine and 5-hydroxy-L-tryptophan are selected according to the highest docking score than that of other TCM compounds and Raloxifene (control). The simulation from molecular dynamics is helpful in analyzing and detecting the protein-ligand interactions. After a comparing the control and the Apo form, then based on the docking poses, hydrophobic interactions, hydrogen bond and structure variations, this research postulates that S-allylmercaptocysteine may be more appropriate than other compounds for protein-ligand interaction. Hindawi Publishing Corporation 2014 2014-06-26 /pmc/articles/PMC4098895/ /pubmed/25054138 http://dx.doi.org/10.1155/2014/321486 Text en Copyright © 2014 Tzu-Chieh Hung et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hung, Tzu-Chieh
Lee, Wen-Yuan
Chen, Kuen-Bao
Chan, Yueh-Chiu
Chen, Calvin Yu-Chian
Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
title Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
title_full Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
title_fullStr Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
title_full_unstemmed Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
title_short Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
title_sort investigation of estrogen receptor (esr1) for breast cancer from traditional chinese medicine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098895/
https://www.ncbi.nlm.nih.gov/pubmed/25054138
http://dx.doi.org/10.1155/2014/321486
work_keys_str_mv AT hungtzuchieh investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine
AT leewenyuan investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine
AT chenkuenbao investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine
AT chanyuehchiu investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine
AT chencalvinyuchian investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine